According to Tonix Pharmaceuticals's latest financial reports the company's total assets are $0.13 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.22 B | -6.31% |
2021-12-31 | $0.24 B | 145.36% |
2020-12-31 | $98.18 M | 574.43% |
2019-12-31 | $14.55 M | -44.69% |
2018-12-31 | $26.31 M | -1.63% |
2017-12-31 | $26.75 M | -2.75% |
2016-12-31 | $27.51 M | -41.49% |
2015-12-31 | $47.01 M | 18.91% |
2014-12-31 | $39.54 M | 352.63% |
2013-12-31 | $8.73 M | 312.66% |
2012-12-31 | $2.11 M | 397.6% |
2011-12-31 | $0.42 M | 131.22% |
2010-12-31 | $0.18 M | 1312.03% |
2009-12-31 | $0.01 M | -71.62% |
2008-12-31 | $0.04 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Aerie Pharmaceuticals AERI | $0.37 B | 169.66% | ๐บ๐ธ USA |
Eagle Pharmaceuticals
EGRX | $0.40 B | 190.65% | ๐บ๐ธ USA |